Ken Griffin Landec Corp \Ca\ Transaction History

Citadel Advisors LLC

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	N/A	42,437 New	42,437 $0
Q3 2023 Nov 14, 2023	BUY	N/A	6,915 Added 10.11%	75,321 $0
Q2 2023 Aug 14, 2023	BUY	N/A	68,406 New	68,406 $0
Q4 2022 Feb 14, 2023	BUY	$0.0 - $9.95 $0 - $833,362	83,755 New	83,755 $0
Q2 2022 Aug 15, 2022	SELL	$8.84 - $11.64 $250,357 - $329,656	-28,321 Reduced 61.76%	17,539 $175,000
Q1 2022 May 16, 2022	SELL	$10.07 - $11.93 $42,716 - $50,607	-4,242 Reduced 8.47%	45,860 $531,000
Q2 2021 Aug 16, 2021	SELL	$9.91 - $12.78 $104,312 - $134,522	-10,526 Reduced 17.36%	50,102 $563,000
Q1 2021 May 17, 2021	BUY	$10.44 - $12.22 $19,136 - $22,399	1,833 Added 3.12%	60,628 $643,000
Q4 2020 Feb 16, 2021	BUY	$9.3 - $11.77 $546,793 - $692,017	58,795 New	58,795 $638,000
Q2 2020 Aug 14, 2020	SELL	$7.96 - $11.54 $185,786 - $269,343	-23,340 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.69 - $11.68 $77,553 - $117,792	10,085 Added 76.08%	23,340 $203,000
Q4 2019 Feb 14, 2020	SELL	$9.09 - $11.89 $45,604 - $59,652	-5,017 Reduced 27.46%	13,255 $150,000
Q3 2019 Nov 14, 2019	BUY	$9.66 - $12.36 $61,978 - $79,301	6,416 Added 54.12%	18,272 $198,000
Q2 2019 Aug 14, 2019	SELL	$9.32 - $12.98 $21,911 - $30,515	-2,351 Reduced 16.55%	11,856 $111,000
Q3 2018 Nov 13, 2018	BUY	$12.65 - $15.15 $179,718 - $215,236	14,207 New	14,207 $0
Q4 2017 Feb 09, 2018	SELL	$11.65 - $13.35 $169,530 - $194,269	-14,552 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$11.95 - $13.35 $173,896 - $194,269	14,552	14,552 $188,000

20.4M

65.8K

14.1K

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.